March 15, 2011

Gilead's Hepatitis C Therapy Called Successful

CDC 3-14-11


In early-stage study results reported recently to investors, Gilead Sciences Inc. said its four-drug combination eliminated hepatitis C virus in patients. The trial examined the use of Gilead GS-9256 and GS-9190 with the standard drugs ribavirin and peginterferon. The researchers plan to present their findings at the annual meeting of the European Association for the Study of the Liver, which begins March 30 in Berlin.


Date of Publication

Kristen Hallam, Bloomberg News

Article Type
General media

Article Category
News Briefs


No comments:

Post a Comment